Do normal Egyptians possess anti-desmoglein 3 antibodies?

International Journal of Dermatology

Volumn 54, Issue 10, 2015, Pages 1145-1149

  Saleh, Marwah A ^a   El Bahy, Mohamed M ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b Cairo University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; IMMUNOGLOBULIN G4 ANTIBODY; PESTICIDE; UNCLASSIFIED DRUG; AUTOANTIBODY; DESMOGLEIN 3; IMMUNOGLOBULIN G;

ADULT; AGRICULTURAL WORKER; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTACT EXAMINATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; EGYPTIAN; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST DEGREE RELATIVE; HIGH RISK POPULATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MIDDLE AGED; NONHUMAN; PEMPHIGUS; REFERENCE VALUE; RURAL AREA; SMOKING; STRESS; YOUNG ADULT; ADOLESCENT; AGRICULTURE; ANIMAL; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; EGYPT; IMMUNOLOGY; INSECT BITES AND STINGS; MOSQUITO; PEDIGREE; POULTRY; RISK FACTOR; RURAL POPULATION; SUNLIGHT;

ADOLESCENT; ADULT; AGRICULTURE; ANIMALS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CULICIDAE; DESMOGLEIN 3; EGYPT; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INSECT BITES AND STINGS; MALE; MIDDLE AGED; PEDIGREE; PEMPHIGUS; PESTICIDES; POULTRY; RESIDENCE CHARACTERISTICS; RISK FACTORS; RURAL POPULATION; SUNLIGHT; YOUNG ADULT;

EID: 84942091516     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12662     Document Type: Article

References (22)

1. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005; 366: 61-73.
2. Pisanti S, Sharav Y, Kaufman E, et al. Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974; 38: 382-387.
3. Amagai M, Koch J, Nishikawa T, et al. Pemphigus vulgaris antigen (desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol 1996; 106: 351-355.
4. Diaz LA, Sampaio SA, Rivitti EA, et al. Endemic pemphigus foliaceus (fogo selvagem). I. Clinical features and immunopathology. J Am Acad Dermatol 1989; 20: 657-669.
5. Abida O, Masmoudi A, Rebai A, et al. The familial feature of Tunisian endemic pemphigus foliaceus. Br J Dermatol 2009; 161: 951-953.
6. Abreu-Velez AM, Hashimoto T, Bollag WB, et al. A unique form of endemic pemphigus in northern Colombia. J Am Acad Dermatol 2003; 49: 599-608.
7. Warren SJ, Lin MS, Giudice GJ, et al. The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med 2000; 343: 23-30.
8. Abida O, Kallel-Sellami M, Joly P, et al. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia. J Eur Acad Dermatol Venereol 2009; 23: 1073-1078.
9. Kallel Sellami M, Ben Ayed M, Mouquet H, et al. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus. Clin Exp Immunol 2004; 137: 195-200.
10. Warren SJ, Arteaga LA, Rivitti EA, et al. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol 2003; 120: 104-108.
11. Ahmed AR, Mohimen A, Yunis EJ, et al. Linkage of pemphigus vulgaris antibody to the major histocompatibility complex in healthy relatives of patients. J Exp Med 1993; 177: 419-424.
12. Mohimen A, Narula M, Ruocco V, et al. Presence of the autoantibody in healthy relatives of Italian patients with pemphigus vulgaris. Arch Dermatol Res 1993; 285: 176-177.
13. Torzecka JD, Wozniak K, Kowalewski C, et al. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Arch Dermatol Res 2007; 299: 239-243.
14. Ahmed AR, Yunis EJ, Khatri K, et al. Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1990; 87: 7658-7662.
15. Ahmed AR, Wagner R, Khatri K, et al. Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris. Proc Natl Acad Sci USA 1991; 88: 5056-5060.
16. Tron F, Gilbert D, Mouquet H, et al. Genetic factors in pemphigus. J Autoimmun 2005; 24: 319-328.
17. van Beek N, Rentzsch K, Probst C, et al. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 2012; 7: 49.
18. Brandsen R, Frusic-Zlotkin M, Lyubimov H, et al. Circulating pemphigus IgG in families of patients with pemphigus: comparison of indirect immunofluorescence, direct immunofluorescence, and immunoblotting. J Am Acad Dermatol 1997; 36: 44-52.
19. Sharma VK, Prasad HR, Khandpur S, et al. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Int J Dermatol 2006; 45: 518-522.
20. Hashimoto T, Ogawa MM, Konohana A, et al. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990; 94: 327-331.
21. Eyre RW, Stanley JR. Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest 1988; 81: 807-812.
22. Ishii K, Amagai M, Hall RP, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997; 159: 2010-2017.